Skip to main content Skip to main menu
UF Health University of Florida
National Dental Practice-Based Research Network College of Dentistry
Join The Nation's Network Today

Danny Johnson

National Dental Practice-Based Research Network

Assistant Resesrch Coordinator

Phone: 352-273-5857
Fax: 352-273-7970

Email: jjohnson@dental.ufl.edu

REASEARCH EXPERIENCE

  • 2015 Regional Coordinator, National Dental PBRN Study 5: Factors for Successful Crowns.
  • 2015 Regional Coordinator, National Dental PBRN Study 4: Management of Dentin Hypersensitivity.
  • 2015 Regional Coordinator, National Dental PBRN Study 3: Decision Aids for the Management of Suspicious Occlusal Caries Lesions.
  • 2014- Regional Coordinator, National Dental PBRN Study 1: Cracked Tooth Registry.

PUBLICATIONS

REFEREED PUBLICATIONS

Svetlov SI, Prima V, Glushakova O, Svetlov A, Kirk DR, Gutierrez H, Serebruany VL, Curley KC, Wang KKW and Hayes RL. Neuro-glial and systemic mechanisms of pathological responses in rat models of primary blast overpressure compared to “composite” blast. Front Neurol 3: article 15, 2012. (Acknowledgement: “The authors wish to thank Mr. Danny Johnson for his excellent technical assistance.”)

Glushakova O, Jeromin A, Martinez J, Johnson D, Denslow ND, Streeter J, Hayes R, Mondello S. CSF Protein Biomarker Panel for Assessment of Neurotoxicity Induced by Kainic Acid in Rats. Toxicol Sci 130(1): 158–167, 2012.

Glushakova OY, Johnson D, Hayes RL. Delayed increases in microvascular pathology after experimental traumatic brain injury are associated with prolonged inflammation, blood-brain barrier disruption, and progressive white matter damage. J Neurotrauma. 2014 Jul 1;31(13):1180-93. doi: 10.1089/neu.2013.3080. Epub 2014 May 8.

ABSTRACTS

Glushakova O, Jeromin A, Johnson D, Zhang Z, Hayes RL, Wang KW. Increased levels of brain injury biomarkers: UCHL 1, GFAP and αll-Spectrin break down products in rat model of kainic acid-mediated neurotoxicity. The 29th Annual National Neurotrauma Symposium, Fort Lauderdale, Florida, July 1013, 2011. J Neurotrauma, 28:A39-A39, 2011.

Glushakova O, Jeromin A, Johnson D, Martinez J, Hayes RL, and Mondello S. CSF protein biomarker panel for assessment of neurotoxicity. The 30st Annual National Neurotrauma Symposium, Phoenix, Arizona, July 22-25, 2012. J Neurotrauma 29: p. A196-A197, 2012.

Glushakova O, Jeromin A, Johnson D, Martinez J, Hayes RL, and Mondello S. CSF protein biomarker panel for assessment of neurotoxicity. The 30st Annual National Neurotrauma Symposium, Phoenix, Arizona, July 22-25, 2012. J Neurotrauma 29: p. A196-A197, 2012.

Glushakova O, Mondello S, Johnson D, Heldermon C, Streeter J and Hayes RL. Protein Biomarker Panel of Cisplatin-Induced Neurotoxicity in a Preclinical Model. 52nd Annual Meeting and ToxExpoTM, San Antonio, Texas, USA March 10–14, 2013 The Toxicologist, Supplement to Toxicological Sciences, Volume 132, Issue 1, p.195, 2013.

Glushakova O, Johnson D, Denslow N, and Hayes RL, Different profiles of CSF and serum biomarkers of CNS injury in preclinical models of traumatic brain injury and neurotoxicity. The 31st Annual National

Neurotrauma Symposium, Nashville, Tennessee, August 4–7, 2013. J Neurotrauma, 30 (15): p. A130-A131, 2013.

Glushakova O, Johnson D, Denslow N, and Hayes RL. Different profiles of CSF and serum biomarkers of CNS injury in preclinical models of traumatic brain injury and neurotoxicity. 43rd annual meeting of the Society for Neuroscience, San Diego, California, USA, November 9-13, 2013, in press.